The impact of pulmonary diseases on other chronic conditions is often misunderstood and commonly underreported. More than half the Americans with Chronic Obstructive Pulmonary Disease (COPD) have not ...

Lung cancer poses a potential smoke screen for today’s pulmonologists. Overall, incidence rates continue to decline in the US as other cancers are on the rise, yet a growing number of patients are ...

Optum Arcadia, part of Optum California's medical group and physician network, has partnered with Kivo Health, an AI-enabled virtual care company, to support expanded access to at-home pulmonary ...

One of the key highlights was the discussion of Pulmonary Embolism Response Teams (PERT), addressing controversies in PE management and focusing on personalized, patient-centered care. The CHEST 2024 ...

Youngstown State University will host an evening with Dr. Rana Awdish, a nationally recognized pulmonary and critical care physician ...

AstraZeneca will present over 75 abstracts, including studies on albuterol/budesonide therapy for asthma and triple inhaled therapy for COPD. Biodesix will present data on Nodify Lung tests, ...

The treatments of tomorrow often start as clinical trials today. And when it comes to groundbreaking advancements in pulmonary care, the Temple Lung Center is at the forefront, offering patients ...

Pulmonary hypertension remains one of the most challenging and underdiagnosed conditions in respiratory medicine. However, with a well-structured approach and dedicated efforts, significant ...

Individuals in close proximity to care for interstitial lung disease (ILD) did not have significantly improved outcomes than those at a greater distance, based on data from more than 1600 individuals ...